Editas Medicine Statistics
NASDAQ: EDITHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
2.75+0.02 (+0.73%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
After hours: 2.75 0.00%
Editas Medicine by the numbers
Editas Medicine has a market capitalization of $422.3 million based on 153.58M shares outstanding. With trailing EPS of $-0.68, Editas Medicine is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 3.1% below its 50-day average and 4.1% above its 200-day average.
Average daily trading volume is 2.48M shares, or about $6.8 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
EDIT valuation vs. peer median
| Metric | EDIT | Peer median | Difference |
|---|---|---|---|
| Market cap | $422.35M | $420.89M | +0% |
| Avg. volume | 2.48M | 696.94K | +255% |
Peer median across 8 companies: EIKN, AGMB, ENTX, ZURA, TECX, KYTX, FENC, AUTL.
Valuation
- Market cap
- $422.35M
- EPS (TTM)
- $-0.68
- Shares outstanding
- 153.58M
Price and trading
- Previous close
- 2.73
- Open
- 2.71
- Day range
- 2.66 – 2.85
- 52-week range
- 1.66 – 4.54
- 52-week change
- -30.03%
- Beta
- —
- Volume
- 2.26M
- Average volume
- 2.48M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Aug 5, 2026
Additional statistics
- Market Cap
- 422.35M
- Forward Pe
- -3.65
- Eps
- -0.68
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 4.54
- Week52 Low
- 1.66
- Avg Volume
- 2.48M
- Shares Outstanding
- 153.58M
- Ma50
- 2.84
- Ma200
- 2.64
- Earnings Date
- Aug 5, 2026
- Pct From52w High
- -39.39%
- Pct From52w Low
- 65.66%